Good news for Medicon Valley
June 5, 2008
This week brought two good news for the biotech industry in Medicon Valley and the entire Nordic region:
SwedenBio, the industry association for Swedish biotech companies, announced the yearly survey of the pharmaceutical pipeline in Sweden. The results are promissing - the drug development pipeline in Sweden has increased with 32 projects since 2007. A total number of 142 pharmaceutical drugs are now in development in Swedish biotech and life-science companies. The projects have also matured since last year so a total of 15 projects are now in phase II, compared to only 11 projects in 2007. You can download the full report here.
But the week also brough good news for the Danish biotech industry: Ernst & Young published their yearly analysis of the global biotech industry, with promissing conclusions seen from a Danish point of view. The number of products under development in Denmark increased with 25 % compared to last year, compared to a growth of “only” 9 % in Europe as a whole. According to Ernst & Young the Danish pipeline now consists of 188 products with Germany and Great Britain as the only two European countries with a larger pipeline than the Danish biotech industry! You can download the full report here.
Comments
Got something to say?